Evidence map›Paper›PMID 37778467›Full record

ArticleJournal of controlled release : official journal of the Controlled Release Society2024

Drug and nucleic acid delivery and targeting to the brain.

Deepak Chitkara, Ram I Mahato

Abstract readEditorial
In one paragraph

Article in Journal of controlled release : official journal of the Controlled Release Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Deepak ChitkaraDepartment of Pharmacy, Birla Institute of Technology and Science Pilani, Vidya Vihar, Pilani, Rajasthan 333031, India. Electronic address: deepak.chitkara@pilani.bits-pilani.ac.in.
Ram I MahatoDepartment of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE 68198, USA.

Funding

Lipid nanomedicine targeting multiple signaling pathways of medulloblastomaR01NS128336 · NINDS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Ram I. Mahato · 2022 to 2026
$2.4M
Overcoming Resistance Mechanisms in Hedgehog and Myc-amplified MedulloblastomaR01NS116037 · NINDS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI COULTER, DONALD, MAHATO, RAM I. · 2021 to 2025
$1.9M
NINDS NIH HHS R01 NS116037NINDS NIH HHS R01 NS128336
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BrainDrug Delivery SystemsNucleic AcidsAnimalsHumansNucleic Acids

Identifiers

PMID37778467
PMCPMC12003045

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.